Home » Topics » BioWorld Science

BioWorld Science
RSS

Lack of clinical effect with AVL-3288 in phase Ib trial in schizophrenia patients

Dec. 23, 2019

Genistein analogue AXP-107-11 acts as chemoenhancer in pancreatic ductal adenocarcinoma

Dec. 23, 2019

Zentalis begins phase I/II trial of DDR drug candidate ZN-c3

Dec. 23, 2019

Vaccitech Oncology collaborates with Cancer Research UK on phase I/IIa study of VTP-600 vaccine

Dec. 23, 2019

OP-1250 shrinks ER-positive breast tumors in xenograft models

Dec. 23, 2019

Novel mouse models of chronic sustained hypoxia and chronic intermittent hypoxia

Dec. 23, 2019

FDA approves Ervebo for prevention of Ebola virus disease

Dec. 20, 2019

Cullinan Oncology announces phase I/IIa trials of VK-2019 and CLN-081

Dec. 20, 2019

Axovant reports preliminary findings from expanded access treatment with AXO-AAV-GM1

Dec. 20, 2019

Bone Therapeutics submits CTA for pivotal study of JTA-004 for knee osteoarthritis

Dec. 20, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.